Here's what's on Cramer's calendar.
Pfizer's vulnerability to cheap generics and its weak roster of experimental medicines will be on display Tuesday, when the company reports earnings.
Japan's second-biggest car maker posts a 13.4 percent rise in April-June operating profit and saw improved sales in the U.S.
Facebook's record close on Thursday, fueled by earnings, added $1.6 billion to Mark Zuckerberg's bottom line. USA Today reports.
Get the best of CNBC in your inbox